https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

GLP-1 and GIP Combination Shows Promise for Weight Loss, Cardiometabolic Improvement in Obesity

GLP-1 and GIP Combination Shows Promise for Weight Loss, Cardiometabolic Improvement in Obesity

Maridebart cafraglutide showed promising results for weight management in obesity and type 2 diabetes (T2D), achieving significant weight loss without plateau.

administrator

Related Articles